Cargando…
Progesterone receptor membrane component 1 is phosphorylated upon progestin treatment in breast cancer cells
Menopausal hormone therapy, using estrogen and synthetic progestins, is associated with an increased risk of developing breast cancer. The effect of progestins on breast cells is complex and not yet fully understood. In previous in vitro and in vivo studies, we found different progestins to increase...
Autores principales: | Willibald, Marina, Bayer, Giuliano, Stahlhut, Vanessa, Poschmann, Gereon, Stühler, Kai, Gierke, Berthold, Pawlak, Michael, Seeger, Harald, Mueck, Alfred O., Niederacher, Dieter, Fehm, Tanja, Neubauer, Hans |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5641147/ https://www.ncbi.nlm.nih.gov/pubmed/29069804 http://dx.doi.org/10.18632/oncotarget.19819 |
Ejemplares similares
-
PGRMC1 Promotes Progestin-Dependent Proliferation of Breast Cancer Cells by Binding Prohibitins Resulting in Activation of ERα Signaling
por: Bai, Yingxue, et al.
Publicado: (2021) -
Progesterone receptor membrane component 1 regulates lipid homeostasis and drives oncogenic signaling resulting in breast cancer progression
por: Asperger, Hannah, et al.
Publicado: (2020) -
EpCAM-Independent Enrichment of Circulating Tumor Cells in Metastatic Breast Cancer
por: Schneck, Helen, et al.
Publicado: (2015) -
Correction: EpCAM-Independent Enrichment of Circulating Tumor Cells in Metastatic Breast Cancer
por: Schneck, Helen, et al.
Publicado: (2016) -
Correction to: Progesterone receptor membrane component 1 regulates lipid homeostasis and drives oncogenic signaling resulting in breast cancer progression
por: Asperger, Hannah, et al.
Publicado: (2021)